Clinical trials
Eye Diseases clinical trials
Below are recruiting eye diseases clinical trials, each written for real people, not researchers. We’re tracking 181 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT06860659Enrolling by invitationPhase 4
Hyaluronate eye drops for moderate to severe dry eye
This trial tests whether 0.28% sodium hyaluronate eye drops can help people with moderate to severe dry eye feel better. It's for patients who have significant dry eye symptoms and signs on an eye exam.
Bangkok, BangkokAges 18 years+ - NCT04232982Recruiting
Cyclophotocoagulation during Boston keratoprosthesis eye surgery
This trial looks at whether a specific eye laser treatment done through the white of the eye (called transscleral cyclophotocoagulation) works well and is safe for people getting a Boston keratoprosthesis. It may help improve comfort and vision outcomes for selected patients needing this type of cornea/eye replacement surgery.
Montreal, QuebecAges 18–80 - NCT04658238Recruiting
Dry eye study of the eye microbiome and immune system
This trial looks at how changes in the eye’s normal germs (microbiome) and the immune response may relate to dry eye. It may help researchers better understand what drives symptoms and how to improve care.
BernAges 18 years+ - NCT07634913Recruiting
Mobile App for Eye Disease Detection
This study tests a smartphone-based system designed to help detect diseases affecting the front of the eye. Researchers will develop and refine this mobile tool to see if it can accurately identify common eye conditions using photos taken on a phone or with standard eye-examination equipment.
Guangzhou, GuangdongAges 18 years+ - NCT07001631Recruiting
EMDR for pain relief in children with sickle cell disease
This trial tests if EMDR therapy can help children with sickle cell disease reduce pain interference in daily life. If you or your child has sickle cell disease and experiences significant pain, this study may offer a new way to manage it.
AmsterdamAges 6–18 - NCT07453212Enrolling by invitation
Food supplement for dry eye caused by meibomian gland issues
This trial tests a food supplement designed to improve dry eye symptoms by targeting the microbiome. It may help if you have dry eye due to meibomian gland problems and are not using contact lenses or certain other eye treatments.
IstanbulAges 18–65 - NCT07321769Recruiting
3D eye modeling study for lens and eye structure disorders
This trial uses advanced imaging to create 3D models of the eye in people with lens problems, eye structure anomalies, trauma, or cataract complications. It aims to improve diagnosis and treatment planning for these conditions.
Hangzhou, ZhejiangAges Any age - NCT07525973Enrolling by invitation
Eye Exercises to Help Parkinson's Disease Symptoms
This study tests whether simple eye exercises can help improve symptoms in people with Parkinson's disease. You'll do supervised eye exercises in a clinic to see if they help with movement, balance, or other Parkinson's symptoms.
IsfahanAges 18–80 - NCT02317328Recruiting
Adaptive eye imaging to take very detailed retinal pictures
This study uses special “adaptive optics” equipment to capture very detailed images of the retina (the nerve layer at the back of the eye). It may help improve eye tests for people with eye disease and also includes some healthy volunteers.
Bethesda, MarylandAges 12–120 - NCT07412860Recruiting
Eye drop test for moderate to severe dry eye
This trial tests a new eye drop (FBV_01) compared to a standard hyaluronic acid eye drop for people with moderate to severe dry eye. The goal is to see if the new drop provides better relief.
Cagliari, CAAges 18 years+ - NCT07650708RecruitingPhase 4
Eye Dryness After LASIK Surgery With a New Dry Eye Treatment
This study tests whether a new eye lubricant called Miebo, given before LASIK vision correction surgery, reduces dry eye symptoms afterward. If you have mild-to-moderate dry eyes and need LASIK, this trial may help you stay more comfortable during your recovery.
Bozeman, MontanaAges 18 years+ - NCT06964269RecruitingPhase 4
Acthar Gel for dry eye and autoimmune disease
This trial tests a new injectable medicine, Acthar Gel, for moderate to severe dry eye and eye pain linked to autoimmune disease. It aims to see if the drug can relieve these symptoms safely.
Nashville, TennesseeAges 18–85 - NCT03358979Recruiting
3D eye-surface testing for severe dry eye
This study looks at how a specific eye-surface marker (EMMPRIN) changes on the surface cells in people with severe dry eye. It may help researchers understand disease severity and how new treatments could work for severe symptoms.
ParisAges 18 years+ - NCT06766357RecruitingPhase 3
Cyclosporin gel for moderate to severe dry eye
This study tests a gel form of cyclosporine for people with moderate to severe dry eye that hasn't improved with other treatments. The gel is applied to the eye to help reduce inflammation and increase tear production.
Xiamen, FujianAges 18 years+ - NCT07063719Recruiting
Finding cell markers for rare eye diseases in adults
This study looks for biological markers in the blood or eye samples of people with rare eye diseases compared to healthy volunteers. It aims to better understand and diagnose these conditions.
ParisAges 18 years+ - NCT07746804Recruiting
School program to prevent nearsightedness in children
This study tests a school-based program to help prevent nearsightedness (myopia) in children who are not yet nearsighted but have a higher risk of developing it. It uses a simple, non-invasive method called auricular acupressure, which involves placing small seeds on the ear, to see if it can keep eyes healthy and reduce the chance of needing glasses.
Shanghai, Shanghai MunicipalityAges 6–11 - NCT07746752Recruiting
School program to prevent nearsightedness in kids with good eye reserve
This study tests whether a school-based program can help prevent nearsightedness (myopia) in children who currently have good distance vision and enough 'eye reserve' (hyperopic reserve) to potentially avoid becoming nearsighted. It focuses on early elementary students to see if simple activities can keep their eyes healthy.
Shanghai, Shanghai MunicipalityAges 6–11 - NCT06544447RecruitingPhase 1/Phase 2
Ear nerve stimulation for dry eye with blocked oil glands
This trial tests a gentle nerve stimulation device placed on the ear to see if it can improve dry eye symptoms caused by blocked oil glands. It may offer a new, drug-free option for relief.
Beijing, Beijing MunicipalityAges 18–65 - NCT04946721Recruiting
Study of eye-surface disease tests and targeted treatment
This study looks at how an “ocular surface” condition can be identified using tests (biomarkers) and how a targeted treatment may help. You may qualify if you’re an adult receiving eye care at specific University of Maryland locations.
Baltimore, MarylandAges 18 years+ - NCT07322302Recruiting
Comparing two approaches for repeat eyelash surgery
This study compares two ways of doing repeat surgery for trichiasis (eyelashes turning inward) on the upper eyelid. The surgeries will be done by specially trained eye care workers, and the goal is to see which approach works better.
Chapel Hill, North CarolinaAges 18 years+ - NCT06295263Recruiting
AI for diagnosing and treating brain diseases in older adults
This study uses artificial intelligence to help diagnose and treat brain diseases that affect older adults, such as Parkinson's and Alzheimer's. Researchers will compare AI methods with standard care to see if they can improve diagnosis and treatment.
Jinan, ShandongAges 8–100 - NCT07396441RecruitingPhase 4
Kelulut honey therapy for juvenile glaucoma
This trial tests if adding Kelulut honey to standard treatment can help protect the optic nerve in young people with juvenile open-angle glaucoma. It looks at eye pressure, nerve thickness, and dry eye symptoms.
Kota Bharu, KelantanAges 15–40 - NCT07566806Recruiting
Cord Plasma Eye Drops for Nerve Pain in the Eye
This trial tests whether special eye drops made from cord plasma (a blood product) can reduce chronic eye pain caused by damaged nerves in the cornea (the clear front part of your eye). You may qualify if you have had eye pain for at least 3 months without obvious surface damage.
Singapore, SingaporeAges 21 years+ - NCT05012033Recruiting
Study how high-dose steroids move through the body
This study measures blood levels of high-dose steroid medicines (prednisolone or related steroids) to understand how the body processes them in different real-life situations. It may help improve how steroids are dosed and monitored for people needing short-term or longer-term anti-inflammatory treatment.
LondonAges 18–75
Hear when a new Eye Diseases trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for eye diseases?
- Yes. Clin2 currently lists 181 recruiting eye diseases studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a eye diseases trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a eye diseases trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.